Encompass Health Corporation $EHC Holdings Reduced by Great Lakes Advisors LLC

Great Lakes Advisors LLC lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 40.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 121,085 shares of the company’s stock after selling 81,572 shares during the period. Great Lakes Advisors LLC owned 0.12% of Encompass Health worth $15,380,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Tectonic Advisors LLC raised its stake in Encompass Health by 1.6% during the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after acquiring an additional 82 shares in the last quarter. Global Retirement Partners LLC increased its holdings in shares of Encompass Health by 23.0% during the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares during the period. EP Wealth Advisors LLC raised its stake in shares of Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares in the last quarter. Natural Investments LLC lifted its holdings in Encompass Health by 1.2% in the third quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock worth $991,000 after purchasing an additional 89 shares during the period. Finally, TD Private Client Wealth LLC grew its position in Encompass Health by 1.1% in the 3rd quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock valued at $1,044,000 after buying an additional 91 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. UBS Group upped their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Barclays lifted their price target on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $142.86.

Encompass Health Trading Down 1.3%

Encompass Health stock opened at $94.44 on Friday. The firm has a market cap of $9.50 billion, a price-to-earnings ratio of 17.85, a price-to-earnings-growth ratio of 1.54 and a beta of 0.74. Encompass Health Corporation has a 1 year low of $92.53 and a 1 year high of $127.99. The firm’s 50 day moving average price is $106.45 and its two-hundred day moving average price is $114.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.04. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The company’s revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company posted $1.03 EPS. On average, research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.